Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Glod

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Journal of Personalized Medicine|January 8, 2015
Next generation sequencing as an aid to diagnosis and treatment of an unusual pediatric brain cancerJohn Glod, Mihae Song, Archana Sharma, et al.
The American Journal of Surgical Pathology|July 9, 2025
DNA Methylation Profiling Separates SDH-Deficient GISTs From KIT-PDGFRA-Driven GISTs and Identifies Predictive Biomarkers for Targeted TherapyMałgorzata Chłopek, Jerzy Lasota, Omkar Singh, et al.
Journal of Cancer Research and Clinical Oncology|May 3, 2024
Germline findings in cancer predisposing genes from a small cohort of chordoma patientsMargarita Raygada, Liny John, Anne Liu, et al.
Endocrine-Related Cancer|December 11, 2025
The Prostate is a Common Site of Disease in Patients with MEN2B and Medullary Thyroid CarcinomaIra L Kraft, Srivandana Akshintala, Andrea Gross, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2024
Tumor Volume Doubling Time of Less Than One Year is Associated with a Higher Risk of Death from Medullary Thyroid CancerNoha Behairy, Anthony J Leonardi, Sriram Gubbi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I-Related Plexiform NeurofibromasLauren H Boal, John Glod, Melissa Spencer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
A Phase II Trial of Vandetanib in Children and Adults with Succinate Dehydrogenase-Deficient Gastrointestinal Stromal TumorJohn Glod, Fernanda I Arnaldez, Lori Wiener, et al.
Pediatric Blood & Cancer|June 22, 2023
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocolMary Frances Wedekind, Karlyne M Reilly, Jaydira Del Rivero, et al.
Neuro-Oncology|August 1, 2023
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)Michelle Monje, Tabitha Cooney, John Glod, et al.
Cell Reports|July 29, 2022
High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibitionJinyang Cai, Sheeba Jacob, Richard Kurupi, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Journal of Personalized Medicine|January 8, 2015
Next generation sequencing as an aid to diagnosis and treatment of an unusual pediatric brain cancerJohn Glod, Mihae Song, Archana Sharma, et al.
The American Journal of Surgical Pathology|July 9, 2025
DNA Methylation Profiling Separates SDH-Deficient GISTs From KIT-PDGFRA-Driven GISTs and Identifies Predictive Biomarkers for Targeted TherapyMałgorzata Chłopek, Jerzy Lasota, Omkar Singh, et al.
Journal of Cancer Research and Clinical Oncology|May 3, 2024
Germline findings in cancer predisposing genes from a small cohort of chordoma patientsMargarita Raygada, Liny John, Anne Liu, et al.
Endocrine-Related Cancer|December 11, 2025
The Prostate is a Common Site of Disease in Patients with MEN2B and Medullary Thyroid CarcinomaIra L Kraft, Srivandana Akshintala, Andrea Gross, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2024
Tumor Volume Doubling Time of Less Than One Year is Associated with a Higher Risk of Death from Medullary Thyroid CancerNoha Behairy, Anthony J Leonardi, Sriram Gubbi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I-Related Plexiform NeurofibromasLauren H Boal, John Glod, Melissa Spencer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
A Phase II Trial of Vandetanib in Children and Adults with Succinate Dehydrogenase-Deficient Gastrointestinal Stromal TumorJohn Glod, Fernanda I Arnaldez, Lori Wiener, et al.
Pediatric Blood & Cancer|June 22, 2023
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocolMary Frances Wedekind, Karlyne M Reilly, Jaydira Del Rivero, et al.
Neuro-Oncology|August 1, 2023
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)Michelle Monje, Tabitha Cooney, John Glod, et al.
Cell Reports|July 29, 2022
High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibitionJinyang Cai, Sheeba Jacob, Richard Kurupi, et al.
Pageof 6